Literature DB >> 25437577

The current status of emergency operations at a high-volume cancer center.

Koji Komori1, Kenya Kimura, Takashi Kinoshita, Seiji Ito, Tetsuya Abe, Yoshiki Senda, Kazunari Misawa, Yuichi Ito, Norihisa Uemura, Seiji Natsume, Ryosuke Kawai, Jiro Kawakami, Tomonari Asano, Yoshinori Iwata, Shintaro Kurahashi, Masayuki Tsutsuyama, Itaru Shigeyoshi, Yasuhiro Shimizu.   

Abstract

This study aimed to assess the pathogenic causes, clinical conditions, surgical procedures, in-hospital mortality, and operative death associated with emergency operations at a high-volume cancer center. Although many reports have described the contents, operative procedures, and prognosis of elective surgeries in high-volume cancer centers, emergency operations have not been studied in sufficient detail. We retrospectively enrolled 28 consecutive patients who underwent emergency surgery. Cases involving operative complications were excluded. The following surgical procedures were performed during emergency operations: closure in 3 cases (10.7%), diversion in 22 cases (78.6%), ileus treatment in 2 cases (7.1%), and hemostasis in 1 case (3.6%). Closure alone was performed only once for peritonitis. Diversion was performed in 17 cases (77.3%) of peritonitis, 4 cases (18.2%) of stenosis of the gastrointestinal tract, and 1 case (4.5%) of bleeding. There was a significant overall difference (P = 0.001). The frequency of emergency operations was very low at a high-volume cancer center. However, the recent shift in treatment approaches toward nonoperative techniques may enhance the status of emergency surgical procedures. The results presented in this study will help prepare for emergency situations and resolve them as quickly and efficiently as possible.

Entities:  

Keywords:  Emergency operations; High-volume cancer center

Mesh:

Year:  2014        PMID: 25437577      PMCID: PMC4254230          DOI: 10.9738/INTSURG-D-14-00122.1

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  8 in total

1.  Chemotherapy with bevacizumab for metastatic colorectal cancer: a retrospective review of 181 Japanese patients.

Authors:  Seiya Saito; Naoko Hayashi; Nobutaka Sato; Masaaki Iwatsuki; Yoshifumi Baba; Yasuo Sakamoto; Yuji Miyamoto; Masayuki Watanabe; Minoru Yoshida; Kenji Sakai; Takashi Katsumori; Shigeru Katahuchi; Nobuyuki Shigaki; Kazutaka Yamada; Masami Kimura; Tomio Tanigawa; Sadamu Takano; Masafumi Kuramoto; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2012-06-05       Impact factor: 3.402

2.  Iatrogenic perforation at therapeutic colonoscopy: should the endoscopist attempt closure using endoclips or transfer immediately to surgery?

Authors:  K Taku; Y Sano; K I Fu; Y Saito
Journal:  Endoscopy       Date:  2006-04       Impact factor: 10.093

Review 3.  Managing patients treated with bevacizumab combination therapy.

Authors:  Michael S Gordon; David Cunningham
Journal:  Oncology       Date:  2005-11-21       Impact factor: 2.935

4.  Complications associated with postoperative adjuvant radiation therapy for advanced rectal cancer.

Authors:  Koji Komori; Kenya Kimura; Takashi Kinoshita; Tsuyoshi Sano; Seiji Ito; Tetsuya Abe; Yoshiki Senda; Kazunari Misawa; Yuichi Ito; Norihisa Uemura; Ryosuke Kawai; Yasuhiro Shimizu
Journal:  Int Surg       Date:  2014 Mar-Apr

5.  Hospital variation in 30-day mortality after colorectal cancer surgery in denmark: the contribution of hospital volume and patient characteristics.

Authors:  Merete Osler; Lene H Iversen; Anders Borglykke; Solvej Mårtensson; Signe Daugbjerg; Henrik Harling; Torben Jørgensen; Birgitte Frederiksen
Journal:  Ann Surg       Date:  2011-04       Impact factor: 12.969

6.  Analysis of colonoscopic perforations at a local clinic and a tertiary hospital.

Authors:  Toshihiko Sagawa; Satoru Kakizaki; Haruhisa Iizuka; Yasuhiro Onozato; Naondo Sohara; Shinichi Okamura; Masatomo Mori
Journal:  World J Gastroenterol       Date:  2012-09-21       Impact factor: 5.742

7.  Analysis of adverse events of bevacizumab-containing systemic chemotherapy for metastatic colorectal cancer in Japan.

Authors:  Taichi Isobe; Keita Uchino; Chinatsu Makiyama; Hiroshi Ariyama; Shuji Arita; Shingo Tamura; Masato Komoda; Hitoshi Kusaba; Tsuyoshi Shirakawa; Taito Esaki; Kenji Mitsugi; Shigeo Takaishi; Koichi Akashi; Eishi Baba
Journal:  Anticancer Res       Date:  2014-04       Impact factor: 2.480

8.  Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy.

Authors:  H Birgisson; L Påhlman; U Gunnarsson; B Glimelius
Journal:  Br J Surg       Date:  2008-02       Impact factor: 6.939

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.